Post-induction, final risk stratification categorised nearly half of BCP-ALL patients as HR (1058/2277, 46%) with the rest divided between final SR (593, 26%) and final IR (626, 28%) (Table 1). The gene discussed is OPN1SW; the disease is acute lymphoblastic leukemia.